• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic Society

    Teva to Present New Respiratory Data at 2015 Annual International Meeting of the American Thoracic Society

  2. Mylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update

    Mylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update

  3. Mylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update

    Mylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update

  4. ADR Shares End Mixed; Teva Declines

    ADR Shares End Mixed; Teva Declines

  5. Soros takes stakes in homebuilders Lennar, D.R. Horton

    Soros takes stakes in homebuilders Lennar, D.R. Horton

  6. IndexIQ Announces May 2015 M&A Deal Holdings in IQ Merger Arbitrage ETF (Ticker: MNA)

    IndexIQ Announces May 2015 M&A Deal Holdings in IQ Merger Arbitrage ETF (Ticker: MNA)

  7. Research and Markets: Tuberculosis Testing Market - Global Industry Analysis 2014-2020

    Research and Markets: Tuberculosis Testing Market - Global Industry Analysis 2014-2020

  8. Research and Markets: Global Active Pharmaceutical Ingredients (API) Market 2014-2020: Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured

    Research and Markets: Global Active Pharmaceutical Ingredients (API) Market 2014-2020: Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured

  9. Research and Markets: Cognitive Impairment - Pipeline Review, H1 2015

    Research and Markets: Cognitive Impairment - Pipeline Review, H1 2015

  10. Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results

    Eagle Pharmaceuticals, Inc. Reports First Quarter 2015 Results

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.